Cancer BiologybioRxivPreprint
A New Class of Precision Therapeutics that Inhibit Prostate Cancer Mediated Bone Destruction
Fangfang Qiao, Ryan R. Gordon, Abhinandan Pattanayak…·Raymond C. Bergan
This paper develops BTE-EN1, a compound that inhibits prostate cancer-mediated bone destruction by targeting cell motility and osteoclast activity, showing efficacy in mice.
1 citation